FAIRFIELD, N.J., June 18, 2012 /PRNewswire/ -- Aperture Health,
Inc. (OTC APRE) announced today that it has executed a Letter of
Intent to acquire Doctors on Call, one of the largest in-home
medical practices in New York City. Doctors on Call,
consisting of over 35 physicians and physician extenders, is
devoted to the care of the frail and/or homebound elderly
throughout New York City.
Founded in 1968, and available seven (7) days a week, Doctors
on Call offers home-based medical care including chronic disease
management, laboratory, diagnostic x-ray, ultrasound, podiatry, and
annual wellness visits to those incapable of accessing traditional
primary care. Further, Doctors on Call has obtained
preferential contracts with major Health Maintenance Organizations
to provide high quality cost-effective medical care to patients
transitioning from the institutional (hospital or skilled nursing
facility) to the home setting providing over 2,000 patient visits a
month.
The Center for Medicare & Medicaid Innovations has selected
Doctors on Call to participate in the Independence at Home
Demonstration Project. Among sixteen (16) participating
practices nationwide, Doctors on Call was the only medical group in
New York City to be selected for
this three (3) year project, which is aimed to improve the lives of
patients living with chronic illnesses by providing quality medical
care right in the patient's own home.
"We are excited with the affiliation with Aperture Health for it
allows Doctors on Call to rapidly expand both its provider network
and range of services to include the lower eight (8) counties of
New York State as well as
New Jersey," stated Dr.
Paul Rosenstock, CEO and Medical
Director of Doctors on Call.
Aperture Health is targeting capital for expansion, as well as,
marketing and management expertise for Doctors on Call to increase
its provider base, to offer in-home specialist services and to
establish strategically placed Diagnostic Urgent Care Private
Practice Sites. Equipped with the latest in diagnostic radiology
and laboratory services and coupled with a highly mobile provider
network, these Private Practice Sites will offer Health Plans and
local communities a flexible and efficient alternative to the long
waits and inconvenience associated with over-crowded emergency
rooms. The elderly can thus be visited in the comforts of the home
and, if necessary, diagnosed and treated in the Urgent Care Private
Practice Site and returned to the home setting at considerable
savings in both time and money to all concerned.
James Hennig, R.Ph, Chief
Executive Officer and Chairman of the Board of Directors commented,
"By combining the clinical and business management expertise of
Aperture Health and Doctors on Call, we open additional pathways to
medical and pharmaceutical service offerings to homecare patients
throughout the NY and NJ areas. Joining forces will allow for
a more seamless 'transitions of care' process for patients from
comprehensive physician evaluation through the initiation of
pharmaceutical care at home."
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad
Therapeutics operates as a fully JCAHO accredited home IV therapy
company, achieving this "gold standard" status in 2007. The company
has built a well respected reputation in its industry for its
therapy expertise and commitment to care for its patient clients.
The company services clients throughout the States of New Jersey, New
York and Connecticut,
providing opportunity for organic growth. Triad's full time
marketing and sales personnel continuously represent the company in
the core services areas, growing and maintaining the company's
referral source base. Patient referrals are made from physicians,
hospitals, insurance companies, veterinarians and hospice care
providers that have established a professional rapport with
Triad.
Safe Harbor
Certain statements in this news release are forward-looking,
including (without limitation) growing revenues and earnings,
expected results from current projects and attracting new
business. Undue reliance should not be placed on such
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties and other
unpredictable factors, many of which are beyond the Company's
control. The Company's actual results, performance and trends could
differ materially from those indicated or implied by such
statements as a result of various factors, including (without
limitation) the continued strengthening of Triad's selling and
marketing functions, continued customer satisfaction, contract
renewal, new product development, continued availability of capable
dedicated personnel, continued cost management, success and
availability of acquisitions, availability of financing and other
factors, as well as by factors applicable to most companies such as
general economic, competitive and other business and civil
conditions. Information regarding certain of those and other
risk factors and cautionary statements that could affect future
results, performance or trends is discussed in the Company's OTC
Disclosure Statement and unaudited management financials posted on
www.pinksheets.com. All of the Company's forward-looking statements
are expressly qualified by all such risk factors and other
cautionary statements. The information set forth herein
speaks only as of the date hereof.
SOURCE Aperture Health, Inc.